Skip to main content

Tapinarof Topical Side Effects

Medically reviewed by Drugs.com. Last updated on Nov 22, 2024.

Applies to tapinarof topical: topical application cream.

Serious side effects of tapinarof topical

Along with its needed effects, tapinarof topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking tapinarof topical:

More common side effects

  • body aches and pain
  • blistering, burning, crusting, dryness, or flaking of the skin
  • burning, itching, and pain in hairy areas
  • chills
  • cough
  • difficulty in breathing
  • ear congestion
  • fever
  • headache
  • itching, scaling, severe redness, soreness, or swelling of the skin
  • loss of voice
  • muscle aches and pains
  • pus at the root of hair
  • shivering
  • sneezing
  • sore throat
  • stuffy or runny nose
  • sweating
  • unusual tiredness or weakness

Less common side effects

  • general feeling of discomfort or illness
  • itching or pain of the genital area
  • joint pain
  • shivering
  • sweating
  • trouble sleeping
  • vomiting

For healthcare professionals

Applies to tapinarof topical: topical cream.

General adverse events

The most frequently reported adverse events included folliculitis and nasopharyngitis.[Ref]

Respiratory

Dermatologic

Adverse events which resulted in treatment discontinuation in greater than 1% of subjects were contact dermatitis (2.9%) and folliculitis (2.8%).[Ref]

Nervous system

References

1. (2022) "Product Information. Vtama (tapinarof topical)." Dermavant Sciences, Inc.

Further information

Tapinarof topical side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.